Ligand · FRT
FRT · N-(2-methoxyethyl)-4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)benzenesulfonamide
FRT, N-(2-methoxyethyl)-4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)benzenesulfonamide (C20 H26 N6 O3 S, 430.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- FRT
- Formula
- C20 H26 N6 O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
FRT in 2 structures; the first of them:
- 2W05 · Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5b · FRT A1299 · binds ILE10, GLY11, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81 and 10 more
- 2W05 · Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5B · FRT A1299 · binds ILE10, GLY11, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81 and 10 more
Residues it binds most
ASP 2, GLN 2, LEU 2, LYS 2, PHE 2, VAL 2, ALA 2, ASN 2, GLU 2, GLY 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.